We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6770:TSEAlps Alpine Co., Ltd. Analysis

Data as of 2026-06-12 - not real-time

NT$67.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Powerchip Semiconductor Manufacturing (6770.TW) is trading in a bullish technical environment, with the short‑term moving average comfortably above the mid‑term and long‑term averages, and price holding above a solid support zone. The momentum indicator sits near the midpoint, while the MACD has turned bearish, suggesting a short‑term pullback risk amid decreasing volume and elevated 30‑day volatility.
Fundamentally, the company posted strong top‑line growth and a positive forward earnings outlook, yet its DCF‑derived fair value sits well below the current market price and the balance sheet carries a high debt load relative to equity. The forward PE is modest compared with a lofty industry average, and the market sentiment index reads “Extreme Greed,” indicating potential over‑optimism. These mixed signals point to a cautious stance, with upside limited unless the price consolidates nearer to intrinsic estimates.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish moving‑average hierarchy supports price stability
  • Bearish MACD divergence signals near‑term downside
  • Decreasing volume and high volatility increase short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust revenue growth and positive forward EPS outlook
  • Forward PE materially lower than industry average
  • Strong cash position offsets high debt, enabling operational flexibility

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strategic position in the global semiconductor foundry market
  • Elevated debt‑to‑equity ratio poses leverage risk over time
  • Geopolitical exposure in Taiwan and cross‑border regulatory environment

Key Metrics & Analysis

Financial Health

Revenue Growth22.10%
Profit Margin15.28%
P/E Ratio14.8
ROE8.15%
ROA3.21%
Debt/Equity36.17
P/B Ratio3.3
Op. Cash FlowNT$20.4B
Free Cash FlowNT$2.7B
Industry P/E36.5

Technical Analysis

TrendBullish
RSI48.0
SupportNT$56.60
ResistanceNT$94.50
MA 20NT$71.60
MA 50NT$62.31
MA 200NT$45.84
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair ValueNT$22.76
Target PriceNT$70.40
Upside/Downside4.45%
GradeFair
TypeBlend

Risk Assessment

Beta0.90
Volatility85.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.